Milrinone Lactate Injection, Solution
Product Images NDC 42677-313

NDC 4267731310 is a prescription Milrinone Lactate Injection, in a 1010 mL Single Dose Vials with a concentration of 10 mg/10 mL (1mg/mL) for intravenous use only. One mL of injection contains Milrinone lactate equivalent to 1 mg Milrinone and 47 mg Dextrose Anhyckous, USP in Water for Injection, USP. The usual dosage is indicated in the provided insert, and the unused portion must be discarded. The injection does not contain a preservative, and the pH range is between 3.2 and 4.0 adjusted with acetic acid or sodium hydroxide, and the concentration of acetic acid can vary between 0.95 mg/mL and 129 mg/mL. It must be stored at 20° to 25°C (68° to 77°F) and should avoid freezing. The manufacturer of the drug is Shandong New Time Pharmaceutical Co. LTD, located in Shandong, China.*

This is a description of Milrinone Lactate Injection, USP, administered through intravenous route using 10x20 mL single-dose vials, with each mL containing 20mg of milrinone lactate and 47mg of Dextrose Anhydrous, USP, in Water for Injection, USP. It is advised to check the package insert for the usual dosage and to discard any unused portion. The product doesn't contain any preservative and should be kept at a controlled room temperature of 20° to 25°C. No freezing should be allowed. The manufacturer is the Shandong New Time Pharmaceutical Co., Ltd, located in Feixian, China.*

Milrinone Lactate Injection is a medication used intravenously for heart failure. It is a single-dose vial containing 10mg/10mL of milrinone lactate equivalent to 4mg milrinone and 47mg Dextrose Anhydrous, USP, in Water for Injection, USP. The usual dosage and storage instructions should be followed as per the package insert. The product is manufactured by Shandong New Time Pharmaceutical Co. Ltd, China. Note that the total concentration of lactic acid can vary between 0.95 mg/mL to 1.29 mg/mL, and it should not be used after single-use, as it does not contain a preservative.*